Unione Europea -
finlandese -
EMA (European Medicines Agency)
numient
amneal pharma europe ltd - levodopan, karbidopan - parkinsonin tauti - parkinson-lääkkeet - parkinsonin taudin aikuispotilaiden oireellinen hoito.
Unione Europea -
finlandese -
EMA (European Medicines Agency)
altargo
glaxo group ltd - retapamuliinin - impetigo; staphylococcal skin infections - antibiootit ja kemoterapeuttiset aineet dermatologiseen käyttöön - short term treatment of the following superficial skin infections: , impetigo;, infected small lacerations, abrasions or sutured wounds. , ks. kohdat 4. 4 ja 5. 1 tärkeää tietoa kliinisen toiminnan retapamuliini vastaan erilaisia staphylococcus aureus. on otettava huomioon viralliset ohjeet antibioottien tarkoituksenmukaisesta käytöstä.
Unione Europea -
finlandese -
EMA (European Medicines Agency)
flebogamma dif (previously flebogammadif)
instituto grifols s.a. - ihmisen normaali immunoglobuliini - mucocutaneous lymph node syndrome; guillain-barre syndrome; bone marrow transplantation; purpura, thrombocytopenic, idiopathic; immunologic deficiency syndromes - immunoseerumit ja immunoglobuliinit, - replacement therapy in adults, children and adolescents (0-18 years) in: , primary immunodeficiency syndromes with impaired antibody production;, hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic luekaemia, in whom prophylactic antibiotics have failed;, hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who failed to respond to pneumococcal immunisation;, hypogammaglobulinaemia in patients after allogenic haematopoietic-stem-cell transplantation (hsct);, congenital aids with recurrent bacterial infections. , immunomodulation in adults, children and adolescents (0-18 years) in: , primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, guillain barré syndrome;, kawasaki disease.
Unione Europea -
finlandese -
EMA (European Medicines Agency)
hizentra
csl behring gmbh - ihmisen normaali immunoglobuliini (scig) - immunologiset puutosyhtymät - immunoseerumit ja immunoglobuliinit, - replacement therapy in adults, children and adolescents (0-18 years) in:- primary immunodeficiency syndromes with impaired antibody production (see section 4. - secondary immunodeficiencies (sid) in patients who suffer from severe or recurrent infections, ineffective antimicrobial treatment and either proven specific antibody failure (psaf)* or serum igg level of.
Finlandia -
finlandese -
Fimea (Suomen lääkevirasto)
panadol 24 mg/ml oraalisuspensio
haleon denmark aps - paracetamol - oraalisuspensio - 24 mg/ml - parasetamoli
Finlandia -
finlandese -
Fimea (Suomen lääkevirasto)
panadol 500 mg peräpuikko
glaxosmithkline consumer healthcare a/s - paracetamolum - peräpuikko - 500 mg - parasetamoli
Finlandia -
finlandese -
Fimea (Suomen lääkevirasto)
panadol 500 mg tabletti
sterling-midy - paracetamolum - tabletti - 500 mg - parasetamoli